1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: March 8 - March 14, 2026
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: March 8 - March 14, 2026

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs

Event Date: 03/09/2026
Location: Fort Lauderdale, FL
Subject: Research and Development Leader Forum
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Event Date: 03/09/2026
Location: Miami Beach, FL
Subject: Leerink Partners Annual Global Healthcare Conference; Speaker: Keynote Address
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Event Date: 03/11/2026
Location: Silver Spring, MD
Subject: Next Generation Risk Assessment Framework
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: J. Frank Nash (Procter and Gamble Co.); Kim Norman (Personal Care Products Council (PCPC)); David Allen (International Collaboration on Cosmetics Safety (ICCS)); Jay Sirois (Consumer Healthcare Products Association (CHPA));

Event Date: 03/12/2026
Location: Washington, DC
Subject: HHS National Conference on Women's Health; Panelist: Microbiome, Inflammation, and Women’s Health
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Event Date: 03/13/2026
Location: Silver Spring, MD
Subject: Establishing a Regulatory Mechanism
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Monopar Therapeutics Inc. and Hendricks Holding Co., Inc. representatives

Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs

No Significant Event

Official Name: Sean R. Keveney, Chief Counsel

No Significant Event

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods

Event Date: 03/09/2026
Location: Mexcio City, Mexico
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: DONALD PRATER; FAZILA SHAKIR; RAVI BHARWANI; LOWELL ZETA; ELIZABETH MILLER; MICHAEL DUTCHER
Non FDA Participant/Group: Several officials and staff from Mexico's regulatory agencies

Event Date: 03/13/2026
Location: Washington DC
Subject: Food Ingredients, Labeling, and Dietary Guidelines
FDA Participant/Group: N/A
Non FDA Participant/Group: Kevin Keane (American Beverage Association); John Stone (BGR’s Health and Life Sciences Practice);

Event Date: 03/13/2026
Location: Washington, DC
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Conor Galvin, Lindsay Brady (Ornua);

Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations

No Significant Event

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives

Event Date: 03/11/2026
Location: Virtual
Subject: Haystack Project
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Haystack Project representatives

Event Date: 03/13/2026
Location: Virtual
Subject: FenBlock and Its Alignment With the Great American Recovery Initiative
FDA Participant/Group: MARTA SOKOLOWSKA; BRIAN FAHEY;
Non FDA Participant/Group: FenBlock and Erving Graves Strategy Group representatives

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics and Research

No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

Event Date: 03/09/2026
Location: Singapore
Subject: International Medical Device Regulators Forum; Speaker: CDRH Update
FDA Participant/Group: KENNETH CAVANAUGH; NEIL MAFNAS;
Non FDA Participant/Group: Global medical device regulators, members of industry, government, and other stakeholders

Official Name: Tracy Beth Høeg M.D., Ph.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products

No Significant Event

Official Name: Timothy Schell, Ph.D., Director, Center for Veterinary Medicine

Event Date: 03/12/2026
Location: Virtual
Subject: Aquaculture Drug Approval Coalition/CVM Triannual Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Aquaculture Drug Approval Coalition (ADAC) representatives

Back to Top